NEW ALBANY, Ind., September 14, 2021 - Healthcare tech start-up RxLightning today announced its partnership with Oncospark to create a unified technology platform that streamlines the specialty medication enrollment and prior authorization process for oncology patients.
To view the full announcement, including downloadable images, bios, and more, click here.
- RxLightning and Oncospark partnering to create a solution that will streamline the specialty drug enrollment and prior authorization process for oncology patients.
- Unified solution will help ensure oncology patients have faster access than ever before to life-saving treatments.
Click image above to view full announcement.
Founded in New Albany, Indiana in 2020, RxLightning digitizes, automates and streamlines the historically complicated manual enrollment process of starting a patient on specialty medications. Specialty medications are expected to account for 70% of new medication launches through 2023. With RxLightning, healthcare providers can quickly and easily complete the enrollment process for every specialty medication in every therapeutic area, helping reduce paperwork, streamline communication and accelerate the speed of therapy for patients. Learn more at rxlightning.com.
Oncospark is a full-service Technology, Data Analytics, Consulting and Revenue Cycle Services firm powered by a team of experienced professionals and technology tools. Oncospark is a technology-enabled service company focused on disruption through innovation from workflow to RCM. Oncospark possesses a unique blend of subject matter experts from clinical to administrative to advocates that drive their augmented automation solutions, relational and transparent data platforms, and proven consulting.
Learn more at www.oncospark.com
Distributed by: Reportable, Inc.